Back
ArrowMark Financial Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
54
BANX
ArrowMark Financial
Last Price:
$21.11
Seasonality Move:
7.69%
Sell
41
ALNY
Alnylam Pharmaceuticals
Last Price:
$271.02
Seasonality Move:
7.6%
Buy
54
ArrowMark Financial (BANX)
is a Buy
Is ArrowMark Financial a Buy, Sell or Hold?
-
The current ArrowMark Financial [BANX] share price is $20.98. The Score for BANX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
BANX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $269.21. The Score for ALNY is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BANX Stock Price Chart
What is ArrowMark Financial's stock price today?
-
The ArrowMark Financial share price today is $20.98Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BANX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $269.21The current trend is moderately bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
BANX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 48.82 | Sell |
Chaikin Money Flow: | 19558 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.88 - 21.24) | Sell |
Bollinger Bands (100): | (20.67 - 21.19) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.33 | Buy |
Relative Strength Index (14 RSI): | 56.44 | Buy |
Chaikin Money Flow: | -958699 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (238.07 - 265.67) | Buy |
Bollinger Bands (100): | (240.5 - 271.04) | Buy |
BANX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.98 | Buy |
20-day SMA: | 21.06 | Sell |
50-day SMA: | 21.06 | Sell |
200-day SMA: | 20.3 | Buy |
8-day EMA: | 20.93 | Buy |
20-day EMA: | 21.01 | Sell |
50-day EMA: | 21.01 | Sell |
200-day EMA: | 20.32 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 266.08 | Buy |
20-day SMA: | 252.48 | Buy |
50-day SMA: | 259.02 | Buy |
200-day SMA: | 252.75 | Buy |
8-day EMA: | 268.02 | Buy |
20-day EMA: | 259.47 | Buy |
50-day EMA: | 256.9 | Buy |
200-day EMA: | 244.06 | Buy |
ArrowMark Financial Earnings Growth & BANX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
ArrowMark Financial Technical Analysis
Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |